A Historic First Step: LSN Medical Advisory Board Holds Inaugural Meeting at ASCO 2025
CHICAGO, IL. We are honored and excited to share another significant milestone in the journey of the Liposarcoma Support Network: the LSN Medical Advisory Board (MAB) held its inaugural meeting on May 30th prior to the 2025 American Society of Clinical Oncology (ASCO) annual meeting in Chicago. This powerful moment officially launched our collaborative work with some of the leading minds in liposarcoma care and research.
Laying the Groundwork for Impact
This first meeting was the beginning of real, focused action for our community, a powerful moment that officially launched our collaborative work with some of the leading minds in liposarcoma care and research.
Bringing together leading oncologists, surgeons, radiologists, and pathologists, we discussed research priorities, patient advocacy needs, and how best to ensure that LSN continues to serve as a reliable source of support and education for individuals and families affected by liposarcoma.
Setting the Stage for Progress
This meeting focused on establishing key goals and priorities for the year ahead, including (but not limited to):
- Clinical trials
- Consensus papers
- Opportunities for collaboration
- Patient education initiatives
- Urgent areas for research and advocacy
Building a Vision Together
The energy in the room was clear: each expert brought not only deep knowledge, but also a shared passion for changing the future of liposarcoma care. Their willingness to guide and partner with LSN represents an extraordinary step forward for our community.